VIB’s core mission is to generate disruptive insights in the molecular underpinning of life and to translate these actively into impactful innovations for patients and society. VIB is an independent research institute where some 1,800 top scientists from Belgium and abroad conduct pioneering basic research. As such, they are pushing the boundaries of what we know about molecular mechanisms and how they rule living organisms such as human beings, animals, plants, and microorganisms.
Based on a close partnership with five Flemish universities – Ghent University, KU Leuven, University of Antwerp, Vrije Universiteit Brussel, and Hasselt University – and supported by a solid funding program, VIB unites the expertise of all its collaborators and research groups in a single institute. VIB’s technology transfer activities translate research results into concrete benefits for society such as new diagnostics and therapies and agricultural innovations.
These applications are often developed by young start-ups from VIB or through collaborations with other companies. This also leads to additional employment and bridges the gap between scientific research and entrepreneurship. VIB also engages actively in the public debate on biotechnology by developing and disseminating a wide range of science-based information
-
Industry
-
Research
-
Company size
-
1,001-5,000 employees
-
Headquarters
-
Gent
-
Type
-
Nonprofit
-
Founded
-
1995
-
Specialties
-
Immunity & Inflammation, Cancer Research, Medical Biotechnology, Neuroscience, Plant Biology, Microbiology, Structural Biology, Computational Biology, Translational Research, Life Sciences, Biotechnology, and Science Communication